Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HT426 is a standardized botanical extract derived from the fruit peduncles of *Hovenia dulcis* (Oriental Raisin Tree), developed by the South Korean company **Neumed**. It is recognized by the **Ministry of Food and Drug Safety (MFDS)** of South Korea as a functional ingredient for liver health. The extract is primarily utilized for its hepatoprotective properties, specifically its ability to mitigate liver damage caused by alcohol consumption and to support overall hepatic function. HT426 is commonly incorporated into functional foods, beverages, and dietary supplements aimed at fatigue recovery and liver protection, leveraging its ability to enhance the metabolism of alcohol and its toxic byproduct, acetaldehyde.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HT426.